Position in OGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,079,411
+$752,847 QoQ
Shares Held
1,187,549
-53.6% QoQ
Ownership
0.452%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,079,411 | 1,187,549 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $15,326,564 | 2,558,692 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $253,293 | 35,327 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,552,017 | 238,953 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,950,137 | 924,601 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $22,042,112 | 1,480,330 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $24,290,400 | 1,628,043 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $34,628,799 | 1,810,183 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $57,710,025 | 2,787,924 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $72,894,705 | 3,877,378 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $48,797,077 | 3,383,986 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $38,013,069 | 2,189,693 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $35,510,932 | 1,706,436 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $35,733,841 | 1,519,296 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $41,177,784 | 1,474,321 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $34,161,611 | 1,459,898 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $46,670,174 | 1,382,820 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $46,962,790 | 1,344,483 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $40,685,066 | 1,336,127 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $44,604,925 | 1,360,321 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $43,032,140 | 1,422,080 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||